These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38803418)

  • 21. Relationship between Doping Prevalence and Socioeconomic Parameters: An Analysis by Sport Categories and World Areas.
    Terreros JL; Manonelles P; López-Plaza D
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurostimulation, doping, and the spirit of sport.
    Pugh J; Pugh C
    Neuroethics; 2021; 14(Suppl 2):141-158. PubMed ID: 34824648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten years of collecting hematological athlete biological passport samples-perspectives from a National Anti-doping Organization.
    Bækken LV; Holden G; Gjelstad A; Lauritzen F
    Front Sports Act Living; 2022; 4():954479. PubMed ID: 35928963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racing Clean in a Tainted World: A Qualitative Exploration of the Experiences and Views of Clean British Elite Distance Runners on Doping and Anti-Doping.
    Shelley J; Thrower SN; Petróczi A
    Front Psychol; 2021; 12():673087. PubMed ID: 34305727
    [No Abstract]   [Full Text] [Related]  

  • 27. Implementation of the biological passport: the experience of the International Cycling Union.
    Zorzoli M; Rossi F
    Drug Test Anal; 2010; 2(11-12):542-7. PubMed ID: 21204287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doping yesterday, today, tomorrow: A challenge for the clinical laboratory.
    Verna R
    Malays J Pathol; 2024 Apr; 46(1):1-10. PubMed ID: 38682840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Meaning of "Clean" in Anti-doping Education and Decision Making: Moving Toward Integrity and Conceptual Clarity.
    Petróczi A; Boardley ID
    Front Sports Act Living; 2022; 4():869704. PubMed ID: 35647537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Clean athlete status' cannot be certified: Calling for caution, evidence and transparency in 'alternative' anti-doping systems.
    Petróczi A; Backhouse SH; Boardley ID; Saugy M; Pitsiladis Y; Viret M; Ioannidis G; Ohl F; Loland S; McNamee M
    Int J Drug Policy; 2021 Jul; 93():103030. PubMed ID: 33250439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using response-time latencies to measure athletes' doping attitudes: the brief implicit attitude test identifies substance abuse in bodybuilders.
    Brand R; Wolff W; Thieme D
    Subst Abuse Treat Prev Policy; 2014 Sep; 9():36. PubMed ID: 25209168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017.
    Aguilar-Navarro M; Salinero JJ; Muñoz-Guerra J; Plata MDM; Del Coso J
    Subst Use Misuse; 2020; 55(8):1361-1369. PubMed ID: 32186429
    [No Abstract]   [Full Text] [Related]  

  • 34. Challenges and perspectives in anti-doping testing.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.
    Al Ghobain M; Konbaz MS; Almassad A; Alsultan A; Al Shubaili M; AlShabanh O
    Subst Abuse Treat Prev Policy; 2016 Apr; 11():14. PubMed ID: 27083557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.
    Gleaves J; Petróczi A; Folkerts D; de Hon O; Macedo E; Saugy M; Cruyff M
    Sports Med; 2021 Sep; 51(9):1909-1934. PubMed ID: 33900578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intended or Unintended Doping? A Review of the Presence of Doping Substances in Dietary Supplements Used in Sports.
    Martínez-Sanz JM; Sospedra I; Ortiz CM; Baladía E; Gil-Izquierdo A; Ortiz-Moncada R
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28976928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacists supporting athletes: a scoping review exploring the knowledge, role and responsibilities of pharmacists in preventing the unintentional use of prohibited substances by athletes.
    Greenbaum DH; McLachlan AJ; Roubin RH; Chaar BB
    Int J Pharm Pract; 2022 May; 30(2):108-115. PubMed ID: 35262700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thirteen years of the fight against doping in figures.
    Aguilar M; Muñoz-Guerra J; Plata MDM; Del Coso J
    Drug Test Anal; 2017 Jun; 9(6):866-869. PubMed ID: 28105782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.